These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20795382)

  • 1. [Immunization of patients with chronic obstructive pulmonary disease with vaccines of Bubo-M and hepatitis B].
    Kulakova NA; Kostinov MP; Magarshak OO; Borisova VN; Polishchuk VB
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (4):27-31. PubMed ID: 20795382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the reactogenicity and immunogenic potency of combined vaccine "Bubo-Kok" in the immunization of children against diphtheria, tetanus, pertussis and viral hepatitis B].
    Fel'dblium IV; Nikolaeva AM; Kuz'ianin AV; Borisova VN; Mel'nikov VA; Chuprinina RP; Perelygina OV; Shalunova NV; Semenova VD; Griaznova DV; Pushkareva EV; Uvitskiĭ AIu; Alekseeva IA; Konopleva OA; Budanov MV; Iakovleva IM
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (5):58-62. PubMed ID: 15554315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of reactogenicity and immunogenicity of Bubo-M, the Russian combined vaccine for immunization of adults against diphtheria, tetanus and viral hepatitis B].
    Fel'dblium IV; Vorob'eva NN; Nikolaeva AM; Borisova VN; Mel'nikov VA; Budanov MV; Iakovleva IA; Kaz'ianin AV; Pushkareva EV; Griaznova DV; Shalunova NV; Perelygina OV; Ozeretskovskiĭ NA; Bektimirov TA; Isaeva NV
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (5):27-30. PubMed ID: 11871295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reactions to and immunogenic properties of the combined vaccine Bubo-M for immunization of children against diphtheria, tetanus and viral hepatitis B].
    Fel'dblium IV; Vorob'eva NN; Nikolaeva AM; Borisova VN; Mel'nikov VA; Budanov MV; Iakovleva IA; Kaz'ianin AV; Pushkareva EV; Griaznov VN; Griaznova DV; Shalunova NV; Perelygina OV; Ozeretskovskiĭ NA; Bektimirov TA
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (6):50-2. PubMed ID: 11881496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S
    BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children.
    Gatchalian SR; Ramakrishnan G; Bock HL; Lefevre I; Jacquet JM
    Hum Vaccin; 2010 Aug; 6(8):664-72. PubMed ID: 20657177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary vaccination of infants with a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine.
    Kanra G; Ceyhan M; Ecevit Z; Bogaerts H; De Grave D; Hauser P; Desmons P
    Pediatr Infect Dis J; 1995 Nov; 14(11):998-1000. PubMed ID: 8584369
    [No Abstract]   [Full Text] [Related]  

  • 9. Reactogenicity of meningococcal C conjugate vaccines when administered at the same time as, or a month prior to or after, tetanus and diphtheria booster vaccinations.
    Southern J; Gelb D; Andrews N; Waight PA; Morris R; Cartwright K; Miller E
    Hum Vaccin; 2006; 2(6):237-42. PubMed ID: 17102644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine.
    Greenberg DP; Wong VK; Partridge S; Chang SJ; Jing J; Howe BJ; Ward JI
    Pediatr Infect Dis J; 2000 Dec; 19(12):1135-40. PubMed ID: 11144372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine.
    Tichmann-Schumann I; Soemantri P; Behre U; Disselhoff J; Mahler H; Maechler G; Sänger R; Jacquet JM; Schuerman L
    Pediatr Infect Dis J; 2005 Jan; 24(1):70-7. PubMed ID: 15665713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvanticity of pGPL-Mc and LRS in the immune responses of monkeys to oral immunization with diphtheria and tetanus toxoids.
    Mirchamsy H; Neway T; Hamedi M; Pilet C
    Comp Immunol Microbiol Infect Dis; 1997 Jan; 20(1):13-20. PubMed ID: 9023036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Fraser A; Vidal L; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005530. PubMed ID: 19588375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination.
    Pichichero ME; Blatter MM; Reisinger KS; Harrison CJ; Johnson CE; Steinhoff MC; Senders SD; Rothstein EP; Willems P; Howe BJ
    Pediatr Infect Dis J; 2002 Sep; 21(9):854-9. PubMed ID: 12352809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA.
    Pool V; Tomovici A; Johnson DR; Greenberg DP; Decker MD
    Vaccine; 2018 Apr; 36(17):2282-2287. PubMed ID: 29573876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SAFETY AND IMMUNOGENICITY OF A NATIONAL COMBINED VACCINE AGAINST PERTUSSIS, DIPHTHERIA, TETANUS, HEPATITIS B AND Hib-INFECTION, CONTAINING ACELLULAR PERTUSSIS COMPONENT, DURING IMMUNIZATION OF ADULTS].
    Feldblyum IV; Nikolaeva AM; Pavroz KA; Danilina TV; Sosnina OY; Vyaznikova TV; Ershov AE; Trofimov DM; Polushkina AV
    Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):46-51. PubMed ID: 27029116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simplified schedule to integrate the hepatitis B vaccine into an expanded program of immunization in endemic countries.
    Lee CY; Lee PI; Huang LM; Chen JM; Chang MH
    J Pediatr; 1997 Jun; 130(6):981-6. PubMed ID: 9202623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa.
    Vesikari T; Rivera L; Korhonen T; Ahonen A; Cheuvart B; Hezareh M; Janssens W; Mesaros N
    Hum Vaccin Immunother; 2017 Jul; 13(7):1505-1515. PubMed ID: 28340322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.
    Embree J; Law B; Voloshen T; Tomovici A
    Clin Vaccine Immunol; 2015 Mar; 22(3):282-90. PubMed ID: 25540274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.